EQS.PA EQUASENS

Healthcare · Health Information Services

9 · Strong Momentum 0.0 · Weak Safe

34.10

+2.56%

About the company

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; after-sales services, and telephone support and maintenance; and data backup, intermediation, and vocational training services. It also provides medical remote monitoring systems, develops a structured medical speech recognition solution, and designs and manufactures connected electronic devices and equipment, as well as offers interoperability solutions. In addition, the company offers financing platform to facilitate multi-donor management, and financing solutions for leased assets for healthcare professionals and others. It serves healthcare facilities and healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.

Website

4.11%

54.05%

1.40

512.6M

13.17

2.59

38.63

52-week range

34.1

low 32.5 high 53.7

Dividend deep dive

EQUASENS operates in the Healthcare sector, specifically in Health Information Services. The company currently offers a dividend yield of 4.11%. This yield is above its 5-year average of 1.9%, and also above its 5-year high of 2.96%. Based on yield theory, the company appears undervalued. The momentum score and value score for the company are not available in the provided data. The overall rating score is also not available.

Dividend history

EQUASENS has an annual dividend payment schedule. The data indicates a dividend increase streak of 0 years. However, the company has shown a consistent pattern of raising its dividend annually from EUR 0.50 in 2014 to EUR 1.25 in 2024, with a projected EUR 1.25 for 2025. The 3-year dividend Compound Annual Growth Rate (CAGR) is 5.98%, and the 5-year CAGR is 6.79%. At this 5-year growth rate, the dividend would double in approximately 10.6 years. For example, the dividend per share was EUR 0.85 in 2019, EUR 1.05 in 2022, and EUR 1.25 in 2024.

Dividend safety

EQUASENS' dividend payout ratio is 54.05%, based on an EPS of EUR 2.59 and a dividend of EUR 1.40. This suggests the dividend is well-covered by earnings. The company's leverage, indicated by a debt-to-equity ratio of 20.467, appears manageable. Liquidity measures include a current ratio of 1.436 and a quick ratio of 1.099. For valuation, one fair value model indicates a value of EUR 67.67, implying the current price is significantly below this. However, another 2-stage fair value model suggests a fair value of EUR 26.51, leading to a margin of safety status of "expensive." The Chowder Number is 10.9, exceeding the 8.0 threshold. The CCC tier and dividend safety status are not available.

Key risks

One fair value model indicates the company is "expensive," suggesting potential overvaluation risk.
The company's dividend increase streak is stated as 0 years, potentially indicating less consistent dividend growth than suggested by history.
The maximum drawdown of 71.6% from peak month 2020-12 to trough month 2025-02 indicates historical price volatility.

What to watch

Monitor future dividend declarations against the current EUR 1.40 market dividend.
Track the payout ratio relative to future earnings per share to assess dividend coverage.
Observe changes in debt-to-equity, current ratio, and quick ratio for leverage and liquidity trends.
Look for updates on the official dividend increase streak and safety status metrics.

Quantic · Free

Unlock the full analysis

Dividend safety read, the key risks, and what to watch next.

Try a sample portfolio Sign up free

AI-generated from Quantic's dividend data · Updated 26 Jul 2026 · Information, not financial advice.